CAR-T cell therapy targeting B cell maturation antigen is effective for relapsed/refractory multiple myeloma, including cases with poor performance status

Du, J; Wei, RH; Jiang, SF; Jiang, H; Li, L; Qiang, WT; He, HY; Shi, L; Ma, QL; Yu, K; Zhang, XY; Ding, HY; Sun, XD; Xiang, F; Zhu, L; Cheng, Z; Fu, WJ

Cheng, Z (通讯作者),6 Dongfeng Rd, Zhengzhou, Henan, Peoples R China.;Fu, WJ (通讯作者),415 Fengyang Rd, Shanghai, Peoples R China.

AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (7): 933

Abstract

In this open-label, single-arm, phase I/II clinical trial, we evaluated the efficacy of anti-B cell maturation antigen (BCMA) chimeric antigen recepto......

Full Text Link